Juan Carlos Meneu-Diaz

Dr. Juan Carlos Meneu-Diaz

orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 August 2009 in Liver Transplantation
Verified
Journal Article
Open access
PDF file
SJSantos Jiménez-Galanes
Santos Jiménez-Galanes
JMJuan Carlos Meneu-Diaz
Juan Carlos Meneu-Diaz
AEAlmudena Moreno Elola-Olaso
Almudena Moreno Elola-Olaso
BPBaltasar Pérez-Saborido
Baltasar Pérez-Saborido
FYFundora-Suarez Yiliam
Fundora-Suarez Yiliam
EGEnrique Moreno González
Enrique Moreno González
Because of the organ shortage, non–heart-beating donors have been proposed as a possible source of grafts for orthotopic liver transplantation (OLT). Despite the widespread use of controlled non–heart-beating donors, there are only a few published studies reporting the outcomes with uncontrolled non–heart-beating donors (UNHBDs). A prospective case-control study on adult patients undergoing OLT was designed. We used normothermic extracorporeal membrane oxygenation (NECMO) in all UNHBDs. Matching 2:1 ratio comparison was performed between a study group (UNHBDs) and a brain death donor (BDD) control group. Between January 2006 and March 2008, a total of 60 patients were included: 20 in the UNHBD group and 40 in the control group. The incidence of ischemic cholangiopathy was 5% (n = 1) for the UNHBD group and 0% for the BDD group (P = 0.15). The rate of primary nonfunction was 10% (n = 2) in UNHBD recipients and 2.5% (n = 1) in BDD recipients (P = 0.21), with graft loss in all of them. Three patients were retransplanted in the UNHBD group (15%), 2 of them because of primary nonfunction and 1 because of ischemic cholangiopathy; no patient was retransplanted in the control group (P = 0.012). After a mean follow-up of 330.4 ± 224.9 days, 1-year cumulative patient survival was 85.5% for the UNHBD group and 87.5% for the BDD group (P = 0.768). One-year cumulative graft survival was 80% in the UNHBD group and 87.5% in the BDD group (P = 0.774). In conclusion, UNHBDs under NECMO are a potential source of organs for OLT with encouraging outcomes potentially comparable to those obtained with BDDs.

1 September 2007 in Transplantation Proceedings
Verified
Journal Article
Closed access
BPB. Pérez-Saborido
B. Pérez-Saborido
SGS. Jiménez de Los Galanes
S. Jiménez de Los Galanes
JMJuan Carlos Meneu-Diaz
Juan Carlos Meneu-Diaz
CRC. Jiménez Romero
C. Jiménez Romero
AEA. Moreno Elola-Olaso
A. Moreno Elola-Olaso
EME. Moreno-González
E. Moreno-González

1 November 2004 in Archives of Surgery
Verified
Journal Article
Open access
PDF file
EME. Moreno-Gonzalez
E. Moreno-Gonzalez
JMJuan Carlos Meneu-Diaz
Juan Carlos Meneu-Diaz
IGI. Garcia
I. Garcia
FCF. Perez Cerdá
F. Perez Cerdá
MAM. Abradelo
M. Abradelo
AMA. Moreno
A. Moreno
Although refinements in surgical technique and improvement in medical management have resulted in better short-term and long-term patient and allograft outcomes,1 the negative impact of renal insufficiency on survival in patients undergoing liver transplantation has been widely reported,2-4 although some aspects are still controversial.5-7

30 August 2003 in Transplantation Proceedings
Verified
Journal Article
Closed access
EME Moreno-Gonzalez
E Moreno-Gonzalez
JMJuan Carlos Meneu-Diaz
Juan Carlos Meneu-Diaz
GGGarcı́a Garcı́a
Garcı́a Garcı́a
CRC Jimenez Romero
C Jimenez Romero
CSC Loinaz Segurola
C Loinaz Segurola
JPJ.Calvo Pulido
J.Calvo Pulido

12 March 2004
Verified
Journal Article
Closed access
AMA Moreno-Elola
A Moreno-Elola
EME Moreno-Gonzalez
E Moreno-Gonzalez
OAO Alonso-Casado
O Alonso-Casado
JMJuan Carlos Meneu-Diaz
Juan Carlos Meneu-Diaz
IGI García-García
I García-García
MAM Abradelo-Usera
M Abradelo-Usera

1 October 2006 in Revista Española de Enfermedades Digestivas
Verified
Journal Article
Open access
PDF file
JMJuan Carlos Meneu-Diaz
Juan Carlos Meneu-Diaz
EGE. Moreno González
E. Moreno González
JGJ. I. García García
J. I. García García
AMA. Moreno
A. Moreno
JMJ. C. Montejo
J. C. Montejo
JSJ. A. Solís-Herruzo
J. A. Solís-Herruzo
Short-bowel transplantation has experienced a substantial growth worldwide following improved results from the late 1990's on, and its coverage by Medicare. According to the International Registry (1985-2005), a total of 1,292 intestinal transplants for 1,210 patients in 65 hospitals across 20 countries have been carried out thus far. to know short-term (6 months) results regarding patient and graft survival from the first Spanish series of intestinal transplants in adult recipients. we present our experience in the assessment of 20 potential candidates to short-bowel transplantation between June 2004 and October 2005. Of these, 10 patients were rejected and 4 were transplanted, which makes up the sample of our study. to this date 5 transplants have been carried out in 4 patients (2 retransplants, 2 desmoid tumors, 1 short bowel syndrome after excision as a result of mesenteric ischemia). Upon study completion and after a mean follow-up of 180 days (range 90-190 days) all recipients are alive, and all grafts but one (75%) are fully operational, with complete digestive autonomy. All patients received induction with alemtuzumab except one, who received thymoglobulin; in all induction was initiated with no steroids. intestinal transplantation represents a therapeutic option that is applicable in our setting and valid for recipients with an indication who have no other feasible alternative to keep their intestinal failure under control.